Burning Rock Biotech Files August 6-K Report
Ticker: BNR · Form: 6-K · Filed: Aug 19, 2024 · CIK: 1792267
Sentiment: neutral
Topics: 6-K, regulatory-filing, press-release
TL;DR
Burning Rock Biotech filed its August 6-K, including a press release. CFO Leo Li signed off.
AI Summary
Burning Rock Biotech Ltd. filed a Form 6-K on August 19, 2024, to report its activities for the month of August 2024. The filing includes a press release as Exhibit 99.1. Leo Li, the Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing provides an update on the company's ongoing activities and disclosures to investors, which is crucial for understanding its current operational status.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves as an update and does not contain significant new financial or strategic information that would immediately alter risk.
Key Players & Entities
- Burning Rock Biotech Ltd. (company) — Registrant
- Leo Li (person) — Chief Financial Officer
- August 19, 2024 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers which are required to furnish to the SEC not less than annually, information which the registrant announces, files or is required to announce or file with any stock exchange on which its securities are traded.
What specific document is included as an exhibit in this filing?
Exhibit 99.1, a press release, is included in this filing.
Who signed this Form 6-K on behalf of Burning Rock Biotech Limited?
Leo Li, the Chief Financial Officer, signed the report.
What is the principal executive office address of Burning Rock Biotech Limited?
The address is No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Does Burning Rock Biotech Ltd. file annual reports on Form 20-F or Form 40-F?
Burning Rock Biotech Ltd. indicated that it files annual reports on Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-08-19 06:04:51
Filing Documents
- d845193d6k.htm (6-K) — 9KB
- d845193dex991.htm (EX-99.1) — 3KB
- 0001193125-24-202429.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Leo Li Name: Leo Li Title: Chief Financial Officer Date: August 19, 2024 3